H-Tyr-Asp-OH Industrial Purity COA Documentation Requirements
- Verification of industrial purity requires rigorous RP-HPLC analysis and specific impurity profiling.
- Essential COA data points include lot numbers, assay percentages, and residual solvent limits.
- Batch consistency is maintained through standardized manufacturing process controls and cGMP compliance.
In the pharmaceutical and biotechnology sectors, the reliability of peptide building blocks is paramount for downstream synthesis success. N-L-Tyrosyl-L-aspartic acid, commonly referred to as Tyr-Asp, serves as a critical intermediate in the construction of complex bioactive peptides. Procuring this material requires more than a simple purchase order; it demands a comprehensive review of quality documentation to ensure the industrial purity meets stringent research and production standards. Buyers must validate that the supplied material aligns with specified chemical identities and impurity profiles to prevent synthesis failures.
When sourcing high-purity H-Tyr-Asp-OH, buyers should prioritize suppliers who provide detailed Certificates of Analysis. These documents serve as the primary verification tool for chemical identity and quality. A robust quality assurance framework ensures that every batch delivered matches the technical specifications required for sensitive coupling reactions. This level of documentation is standard practice for a reputable global manufacturer committed to supplying pharmaceutical intermediates.
HPLC Analysis Methods for ≥98% Purity
The determination of purity for dipeptide intermediates relies heavily on high-performance liquid chromatography (HPLC). For (S)-2-[(S)-2-Amino-3-(4-hydroxy-phenyl)-propionylamino]-succinic acid, reversed-phase chromatography is the industry standard for separating the target compound from potential diastereomers and deletion sequences. Analytical methods typically utilize a C18 column with a gradient elution system involving water and acetonitrile, often modified with trifluoroacetic acid (TFA) to improve peak shape.
Detection is usually performed via UV absorbance at 214 nm or 254 nm, depending on the specific chromophores present in the molecule. A purity claim of ≥98% must be supported by chromatograms showing minimal baseline noise and distinct separation from related substances. Advanced facilities may employ UPLC (Ultra Performance Liquid Chromatography) for higher resolution and faster run times. The analysis report should explicitly state the retention time of the main peak and the percentage area of any impurities detected. This data is critical for process chemists evaluating the suitability of the material for solid-phase peptide synthesis (SPPS) or solution-phase coupling.
Essential COA Data Points for Verification
A Certificate of Analysis (COA) is not merely a formality; it is a legal and technical document that guarantees the quality of the shipment. For bulk procurement, the COA must contain specific data points that allow quality control teams to verify the material upon receipt. The header section should clearly identify the product name, CAS number (87085-11-8), and the specific grade designation. Crucially, the Lot or Batch Number on the COA must match the label on the physical container to ensure traceability.
The core of the document consists of the test results table. Key parameters include the assay value, which confirms the quantity of the active ingredient, and limits for residual solvents such as DMF or DCM used during the manufacturing process. Heavy metal analysis is also standard, ensuring compliance with safety regulations for pharmaceutical applications. Below is a typical specification table found in comprehensive quality documentation:
| Test Parameter | Specification | Typical Result | Test Method |
|---|---|---|---|
| Appearance | White to Off-White Powder | White Powder | Visual |
| Assay (HPLC) | ≥ 98.0% | 98.5% | RP-HPLC |
| Related Substances | ≤ 1.0% | 0.8% | RP-HPLC |
| Loss on Drying | ≤ 5.0% | 3.2% | Gravimetric |
| Residual Solvents | Compliant to ICH Q3C | Compliant | GC |
Each result should be accompanied by the specific test method reference, such as USP, EP, or an internal validated method. This transparency allows purchasing agents and chemists to compare batches over time and assess supplier consistency. Without these specific numerical results, a document is merely a Certificate of Conformance, which lacks the analytical depth required for critical pharmaceutical applications.
Batch Consistency and Quality Assurance Protocols
Maintaining batch-to-batch consistency is the hallmark of a reliable supply chain. Variations in purity or impurity profiles can significantly impact reaction yields in downstream peptide synthesis. To mitigate this risk, manufacturers implement strict quality assurance protocols throughout production. This includes in-process controls during the coupling and deprotection steps of the synthesis route. Regular audits and equipment calibration ensure that the manufacturing process remains stable over long production runs.
For large-scale operations, partnering with a dedicated global manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. ensures access to consistent bulk supply chains. NINGBO INNO PHARMCHEM CO.,LTD. adheres to rigorous quality management systems that prioritize documentation and traceability. This commitment reduces the risk of supply chain disruptions and ensures that every kilogram shipped meets the same high standards as the initial sample. Consistency in industrial purity allows process chemists to lock in reaction parameters without needing to re-optimize conditions for every new lot.
Furthermore, proper storage and handling instructions must be included in the documentation. Peptide intermediates can be sensitive to moisture and light, requiring storage in cool, dry conditions to maintain stability. The COA should specify the retest date or expiration date, enabling inventory managers to implement First-In-First-Out (FIFO) protocols. By understanding and demanding these comprehensive documentation requirements, procurement teams can secure high-quality materials that support efficient and successful drug development pipelines.